Standard BioTools Inc.

NASDAQ: LAB · Real-Time Price · USD
1.22
0.00 (0.00%)
At close: Aug 15, 2025, 2:19 PM

Standard BioTools Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-120.5M -132.76M -138.88M -124.59M -118.65M -89.97M -74.66M -75.72M -84.15M -130.65M -190.1M -178.68M -163.1M -116.7M -59.24M -67.83M -59.99M -55.86M
Depreciation & Amortization
-2.99M 3.32M 4.35M 16.81M 16.94M 16.71M 15.18M 14.89M 14.51M 14.72M 15.03M 15.29M 15.56M 15.63M 15.57M 15.7M 15.79M 15.78M
Stock-Based Compensation
28.79M 29.13M 31.73M 27.74M 25.2M 21.59M 13.12M 11.33M 12.44M 13.99M 14.88M 17.56M 17.39M 16.47M 16.1M 15.83M 15.87M 15.76M
Other Working Capital
-32.77M -43.44M -40.83M -35.6M -3.17M 300K 8.07M 3.88M 1.75M -5.9M -5.3M -7.45M -14.57M -8.76M -23.16M -1.78M 4.4M 3.64M
Other Non-Cash Items
4.5M 11.34M -11.45M -10.09M -9.94M -9.69M 15.18M 926K 4.37M -7.2M 4.38M 5.25M 2.25M 14.65M 3.44M 4.01M 4.41M 4.83M
Deferred Income Tax
n/a n/a n/a -14.51M -14.12M -13.9M -13.9M 1.35M 222K 44.13M 81.92M 79.66M 80.7M 37.5M 21K 1.57M 1.31M 527K
Change in Working Capital
-2.67M -22.29M -29.2M -38.82M -26.44M -22.02M 1.79M -1.19M -8.99M -17.25M -15.48M -17.79M -16.09M -14.58M -19.93M -8.5M -11.97M -4.53M
Operating Cash Flow
-92.88M -111.26M -143.45M -143.46M -127M -97.28M -43.29M -48.41M -61.61M -82.27M -89.37M -77.19M -62.07M -46.75M -44.06M -40.79M -35.9M -24.02M
Capital Expenditures
-12.58M -12.63M -8.36M -5.05M -3.7M -2.6M -2.83M -3.51M -3.87M -3.97M -3.83M -3.53M -3.98M -7.21M -13.26M -23.51M -22.14M -18.61M
Cash Acquisitions
-1.39M -1.39M 278.65M 293.07M 293.07M 293.07M -31.13M -44.16M -44.16M -44.16M n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-159.06M -215.26M -256.12M -265.65M -236.04M -161.24M -94.9M -55.86M -6.84M -144.14M -137.3M -137.3M -137.3M n/a n/a n/a n/a n/a
Sales Maturities Of Investments
210M 289M 349M 315M 265M 178.96M 117.96M 132.96M 144.96M 104M 53M 12M n/a n/a n/a n/a 2.4M 13.17M
Other Investing Acitivies
n/a n/a n/a -13.04M -13.04M 27.93M 72.09M 126.13M 138.13M -40.14M -84.3M -125.98M -137.98M -682K 1.32M 11.88M 23.04M 33.8M
Investing Cash Flow
36.97M 59.72M 363.17M 324.33M 305.29M 295.16M 20.24M 73.6M 134.26M -44.1M -88.13M -129.52M -141.96M -7.89M -11.95M -11.62M 3.29M 17.59M
Debt Repayment
-55M -55M -63.19M -9.44M -10.28M -10.28M -2.08M -833K n/a n/a 18.16M 25M 35M 35M 16.34M 9.5M -501K -501K
Common Stock Repurchased
-161K -29.6M -40.6M -40.73M -41.06M -14M -5.41M -5.8M -5.51M -3.12M -744K -279K -321K -1.36M -1.79M -1.77M -1.75M -838K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-38.94M -39.38M -39.85M -449K -311K -19K 362K -329K -401K 212.59M 212.6M 213.42M 213.39M 302K -136K -261K 20.19M 20.84M
Financial Cash Flow
-54.46M -82.93M -102.62M -49.1M -50.26M -23.98M -6.81M -6.08M -4.92M 210.13M 230.76M 238.32M 248.15M 35.06M 15.96M 9.09M 19.69M 20.33M
Net Cash Flow
-109.9M -134.88M 115.83M 130.99M 127.51M 173.39M -29.82M 19.23M 67.72M 83.46M 52.86M 30.89M 43.5M -19.76M -40.07M -43.03M -12.16M 14.69M
Free Cash Flow
-105.46M -123.89M -151.81M -148.51M -130.7M -99.88M -46.12M -51.91M -65.47M -86.23M -93.19M -80.72M -66.05M -53.96M -57.33M -64.3M -58.04M -42.63M